Tarsus Pharmaceuticals, Inc. | Business Contracts

Amended and Restated License Agreement, dated June 3, 2022, by and between the Registrant and Elanco Tiergesundheit AG (Filed With SEC on August 11, 2022)

Amended and (Filed With SEC on August 11, 2022)

Consulting Agreement, dated (Filed With SEC on May 11, 2022)

Loan and Security Agreement, dated February 2, 2022, by and among (Filed With SEC on May 11, 2022)

Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on October 9, 2020)

Sublease Agreement, dated May 29, 2020, between the Registrant and Avent, Inc., as amended by First Amendment to Sublease Agreement, dated July 30, 2020, between the Registrant... (Filed With SEC on September 25, 2020)

Underwriting Agreement, dated May 2, 2022, by and among the Company, BofA Securities, Inc. and Jefferies LLC (Filed With SEC on May 4, 2022)

Description of the Registrants securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 14, 2022)

Development and license Agreement, between the Registrant and LianBio Ophthalmology, dated as of March, 26, 2021 (Filed With SEC on May 11, 2021)

Description of the Registrants securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2021)

License Agreement, dated January 31, 2019, between the Registrant and Elanco Tiergesundheit AG (Filed With SEC on October 9, 2020)

Management Cash Incentive Plan (Filed With SEC on October 9, 2020)

License Agreement, dated September 3, 2020, between the Registrant and Elanco Tiergesundheit AG (Filed With SEC on October 9, 2020)

Amendment to License Agreement, dated September 3, 2020, between the Registrant and Elanco Tiergesundheit AG (Filed With SEC on October 9, 2020)

Amended and Restated Offer Letter, dated October 8, 2020, between the Registrant and Bobak Azamian, M.D., Ph.D (Filed With SEC on October 9, 2020)

Tarsus Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on October 9, 2020)

Tarsus Pharmaceuticals, Inc. 2020 Equity Incentive Plan and form of agreements thereunder (Filed With SEC on October 9, 2020)

Amended and Restated Investors Rights Agreement, dated September 24, 2020, by and among the Registrant and the other parties thereto (Filed With SEC on October 9, 2020)

Form of Registrants common stock certificate (Filed With SEC on October 9, 2020)

Form of Underwriting Agreement (Filed With SEC on October 9, 2020)

Offer Letter, dated March 15, 2020, between the Registrant and Leo M. Greenstein (Filed With SEC on September 25, 2020)

Office Lease, dated May 28, 2020, between the Registrant and Discovery Business Center LLC (Filed With SEC on September 25, 2020)

Offer Letter, dated June 22, 2020, between the Registrant and Aziz Mottiwala (Filed With SEC on September 25, 2020)

Offer Letter, dated October 29, 2018, between the Registrant and Mark Holdbrook (Filed With SEC on September 25, 2020)

Offer Letter, dated June 4, 2020, between the Registrant and Seshadri Neervannan, Ph.D (Filed With SEC on September 25, 2020)

Tarsus Pharmaceuticals, Inc. 2016 Stock Plan, as amended, and forms of agreements thereunder (Filed With SEC on September 25, 2020)

Tarsus Pharmaceuticals, Inc. (26)